FINCK BARBARA K
Insider CIK 1242116 · FBRX Director · CHRS Chief Medical Officer · CMRA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 31,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 18,353 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 7,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 1,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 1,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 166 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 2,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 18,353 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 31,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 7,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 1,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 1,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 166 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 2,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2025-03-19 | 2025-03-21 | 31,000 | — | $0 | 31,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2024-08-20 | 2024-08-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2024-03-21 | 2024-03-25 | 175,000 | — | $0 | 175,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2023-09-19 | 2023-09-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CMRA Comera Life Sciences Holdi | A Award deriv | 2023-01-04 | 2023-01-06 | 6,756 | $0.25 | $1.7K | 6,756 | SEC↗ |
| CMRA Comera Life Sciences Holdi | P Buy deriv | 2023-01-04 | 2023-02-14 | 6,756 | $0.25 | $1.7K | 6,756 | SEC↗ |
| CMRA Comera Life Sciences Holdi | A Award | 2023-01-04 | 2023-01-06 | 6,756 | $1.23 | $8.3K | 23,033 | SEC↗ |
| CMRA Comera Life Sciences Holdi | P Buy | 2023-01-04 | 2023-02-14 | 6,756 | $1.23 | $8.3K | 23,033 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2022-06-01 | 2022-06-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2022-03-16 | 2022-05-16 | 4,166 | — | $0 | 4,166 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2022-03-16 | 2022-03-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise deriv | 2018-09-10 | 2018-09-12 | 1,760 | — | $0 | 82,941 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2018-09-10 | 2018-09-12 | 1,760 | $18.58 | $32.7K | 37,043 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise | 2018-09-10 | 2018-09-12 | 1,760 | $1.42 | $2.5K | 38,803 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise deriv | 2018-08-13 | 2018-08-15 | 1,760 | — | $0 | 84,701 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise | 2018-08-13 | 2018-08-15 | 1,760 | $1.42 | $2.5K | 38,803 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2018-08-13 | 2018-08-15 | 1,760 | $19.02 | $33.5K | 37,043 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise deriv | 2018-07-10 | 2018-07-11 | 1,260 | — | $0 | 86,461 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise | 2018-07-10 | 2018-07-11 | 1,260 | $1.42 | $1.8K | 38,303 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2018-07-10 | 2018-07-11 | 1,260 | $15.00 | $18.9K | 37,043 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise deriv | 2018-07-09 | 2018-07-11 | 500 | — | $0 | 87,721 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2018-07-09 | 2018-07-11 | 500 | $15.03 | $7.5K | 37,043 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise | 2018-07-09 | 2018-07-11 | 500 | $1.42 | $710 | 37,543 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise deriv | 2018-06-18 | 2018-06-20 | 1,760 | — | $0 | 88,221 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2018-06-18 | 2018-06-20 | 1,760 | $15.00 | $26.4K | 37,043 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise | 2018-06-18 | 2018-06-20 | 1,760 | $1.42 | $2.5K | 38,803 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 130,000 | — | $0 | 130,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award | 2017-12-15 | 2017-12-19 | 7,545 | — | $0 | 34,336 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2017-08-06 | 2017-08-08 | 67,000 | — | $0 | 67,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2016-05-11 | 2016-05-13 | 78,472 | — | $0 | 78,472 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2015-04-01 | 2015-04-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion deriv | 2014-11-12 | 2014-11-12 | 5,286 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion deriv | 2014-11-12 | 2014-11-12 | 21,505 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion | 2014-11-12 | 2014-11-12 | 21,505 | — | $0 | 21,505 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion | 2014-11-12 | 2014-11-12 | 5,286 | — | $0 | 26,791 | SEC↗ |